Vaccinating boys plays key role in HPV prevention

Improving vaccination rates against the human papillomavirus (HPV) in boys is key to protecting both men and women, says new research from University of Toronto Professor Peter A. Newman from the Factor-Inwentash Faculty of Social Work.

HPV has been linked to anal, penile and certain types of in men. Since the virus is also responsible for various cancers in women, vaccinating boys aged 11 to 21 will play a crucial role in reducing across the sexes.

"HPV is the single most common sexually transmitted infection," says Newman, Canada Research Chair in Health and Social Justice. "But now a is available that can change that and help to prevent the cancers that sometimes result."

Newman's research grouped data from 16 separate studies involving more than 5,000 people to analyze rates of HPV vaccine acceptability and examined what factors play a role when determining if young men receive the vaccine.

Vaccinations, particularly new ones, can have difficulty gaining traction among the citizens they were developed to help. This problem can be compounded by a lack of information, misinformation and even about the efficacy and safety of vaccines. Unfortunately, says Newman, misinformation and unfounded vaccine fears can result in cancer deaths that could have been avoided with a simple vaccination.

Logistical barriers can also stifle the spread and acceptance of new vaccines. Basic impediments like out-of-pocket cost, transportation to a clinic and wait times for the vaccine can contribute to overall low vaccination rates.

The biggest factor affecting male HPV is the lack of a well-established connection linking HPV in men to a life-threatening illness. The correlation between HPV and in women is responsible for popularizing the vaccine among young women. Unfortunately, a similar connection that would motivate males to get the vaccine has not yet been established. That needs to change, says Newman.

"The idea of an HPV vaccine for boys is new in Canada and so far it has had a low adoption rate," says Newman. "So we need physicians, social workers and public health care institutions to be more active conveying the benefits of the vaccine for boys and the positive role it can help play keeping Canadians safe and healthy."

More information: Sex Transm Infect doi:10.1136/sextrans-2012-050980

add to favorites email to friend print save as pdf

Related Stories

Sexually transmitted HPV declines in US teens

Jun 19, 2013

The number of US girls with the sexually transmitted disease HPV has dropped by about half even though relatively few youths are getting the vaccine, research showed on Wednesday.

Study highlights attitudes toward HPV vaccination for boys

Jan 29, 2013

(Boston)- A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents/guardians were receptive toward vaccinating boys against Human Papilloma Virus (HPV). However, racial/ethnic ...

Recommended for you

Nanopatch to help WHO battle polio

6 hours ago

The World Health Organisation's (WHO) battle against polio has a new weapon after joining forces with Vaxxas, the biotechnology company responsible for developing revolutionary vaccine delivery method the Nanopatch.

Obama's Ebola response: Is it enough and in time?

10 hours ago

President Barack Obama declared Tuesday that the Ebola epidemic in West Africa could threaten security around the world, and he ordered 3,000 U.S. military personnel to the region in emergency aid muscle ...

User comments